Skip to Main Content

Paper Details

Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311).
J Clin Oncol
177
2022
Author NameAffiliation
Joaquin J GarciaMayo Clinic
Umamaheswar DuvvuriUPMC Hillman Cancer Center
Bert W O'MalleyUniversity of Pennsylvania
Bert W O'MalleyUniversity of Pennsylvania
Wayne M KochJohns Hopkins University
  • 1 - 5

Datasets

Release 1.2